vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and GRACO INC (GGG). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $593.2M, roughly 1.4× GRACO INC). GRACO INC runs the higher net margin — 22.3% vs 0.5%, a 21.8% gap on every dollar of revenue. On growth, GRACO INC posted the faster year-over-year revenue change (8.1% vs 7.5%). Over the past eight quarters, GRACO INC's revenue compounded faster (9.8% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Graco Inc. is an American industrial company that specializes in the development and manufacturing of fluid-handling systems and products. The company is headquartered in Minneapolis, Minnesota, and markets its products to customers worldwide.
ACHC vs GGG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $593.2M |
| Net Profit | $4.5M | $132.5M |
| Gross Margin | — | 51.7% |
| Operating Margin | — | 26.7% |
| Net Margin | 0.5% | 22.3% |
| Revenue YoY | 7.5% | 8.1% |
| Net Profit YoY | -50.8% | 21.9% |
| EPS (diluted) | $0.05 | $0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $593.2M | ||
| Q3 25 | $851.6M | $543.4M | ||
| Q2 25 | $869.2M | $571.8M | ||
| Q1 25 | $770.5M | $528.3M | ||
| Q4 24 | $774.2M | $548.7M | ||
| Q3 24 | $815.6M | $519.2M | ||
| Q2 24 | $796.0M | $553.2M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $132.5M | ||
| Q3 25 | $36.2M | $137.6M | ||
| Q2 25 | $30.1M | $127.6M | ||
| Q1 25 | $8.4M | $124.1M | ||
| Q4 24 | $32.6M | $108.7M | ||
| Q3 24 | $68.1M | $122.2M | ||
| Q2 24 | $78.5M | $133.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 51.7% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 52.4% | ||
| Q1 25 | — | 52.6% | ||
| Q4 24 | — | 50.9% | ||
| Q3 24 | — | 53.2% | ||
| Q2 24 | — | 54.4% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 26.7% | ||
| Q3 25 | 4.7% | 30.3% | ||
| Q2 25 | 5.8% | 27.5% | ||
| Q1 25 | 1.7% | 27.3% | ||
| Q4 24 | 4.9% | 23.7% | ||
| Q3 24 | 12.1% | 28.1% | ||
| Q2 24 | 13.4% | 29.2% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 22.3% | ||
| Q3 25 | 4.3% | 25.3% | ||
| Q2 25 | 3.5% | 22.3% | ||
| Q1 25 | 1.1% | 23.5% | ||
| Q4 24 | 4.2% | 19.8% | ||
| Q3 24 | 8.4% | 23.5% | ||
| Q2 24 | 9.9% | 24.0% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.78 | ||
| Q3 25 | $0.40 | $0.82 | ||
| Q2 25 | $0.33 | $0.76 | ||
| Q1 25 | $0.09 | $0.72 | ||
| Q4 24 | $0.36 | $0.63 | ||
| Q3 24 | $0.74 | $0.71 | ||
| Q2 24 | $0.85 | $0.77 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $624.1M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $2.7B |
| Total Assets | $5.5B | $3.3B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $624.1M | ||
| Q3 25 | $118.7M | $618.7M | ||
| Q2 25 | $131.4M | $534.9M | ||
| Q1 25 | $91.2M | $536.1M | ||
| Q4 24 | $76.3M | $675.3M | ||
| Q3 24 | $82.1M | $764.5M | ||
| Q2 24 | $77.2M | $666.0M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.7B | ||
| Q3 25 | $3.1B | $2.6B | ||
| Q2 25 | $3.1B | $2.5B | ||
| Q1 25 | $3.0B | $2.5B | ||
| Q4 24 | $3.1B | $2.6B | ||
| Q3 24 | $3.0B | $2.5B | ||
| Q2 24 | $3.0B | $2.4B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $3.3B | ||
| Q3 25 | $6.4B | $3.2B | ||
| Q2 25 | $6.3B | $3.0B | ||
| Q1 25 | $6.1B | $3.0B | ||
| Q4 24 | $6.0B | $3.1B | ||
| Q3 24 | $5.9B | $3.0B | ||
| Q2 24 | $5.7B | $2.9B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $196.3M |
| Free Cash FlowOCF − Capex | — | $184.3M |
| FCF MarginFCF / Revenue | — | 31.1% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | 13.78× | 1.48× |
| TTM Free Cash FlowTrailing 4 quarters | — | $637.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $196.3M | ||
| Q3 25 | $73.2M | $179.2M | ||
| Q2 25 | $133.5M | $182.7M | ||
| Q1 25 | $11.5M | $125.4M | ||
| Q4 24 | $116.7M | $185.2M | ||
| Q3 24 | $163.1M | $178.6M | ||
| Q2 24 | $171.1M | $139.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $184.3M | ||
| Q3 25 | $-63.0M | $175.7M | ||
| Q2 25 | $-34.2M | $163.1M | ||
| Q1 25 | $-163.2M | $114.8M | ||
| Q4 24 | $-86.8M | $171.3M | ||
| Q3 24 | $-27.1M | $159.2M | ||
| Q2 24 | $16.9M | $102.7M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 31.1% | ||
| Q3 25 | -7.4% | 32.3% | ||
| Q2 25 | -3.9% | 28.5% | ||
| Q1 25 | -21.2% | 21.7% | ||
| Q4 24 | -11.2% | 31.2% | ||
| Q3 24 | -3.3% | 30.7% | ||
| Q2 24 | 2.1% | 18.6% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 2.0% | ||
| Q3 25 | 16.0% | 0.6% | ||
| Q2 25 | 19.3% | 3.4% | ||
| Q1 25 | 22.7% | 2.0% | ||
| Q4 24 | 26.3% | 2.5% | ||
| Q3 24 | 23.3% | 3.7% | ||
| Q2 24 | 19.4% | 6.6% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.48× | ||
| Q3 25 | 2.02× | 1.30× | ||
| Q2 25 | 4.43× | 1.43× | ||
| Q1 25 | 1.37× | 1.01× | ||
| Q4 24 | 3.58× | 1.70× | ||
| Q3 24 | 2.39× | 1.46× | ||
| Q2 24 | 2.18× | 1.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
GGG
| Industrial | $284.3M | 48% |
| Contractor | $265.5M | 45% |
| Other | $43.4M | 7% |
